XML 125 R28.htm IDEA: XBRL DOCUMENT
v3.24.4

SHARE CAPITAL AND OTHER EQUITY INSTRUMENTS (Tables) | 9 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2024 | Dec. 31, 2023
Equity [Abstract] |  |
SCHEDULE OF STOCK OPTION | A summary of the stock option activity under the Company’s incentive plan for the nine months ended September 30, 2024 is presented below: SCHEDULE OF STOCK OPTION
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Grant Date Fair Value |  |  | Weighted Average Remaining Contractual Term (years) |  |  | Aggregate Intrinsic Value |
Outstanding at December 31, 2023 |  |  | 2,022 |  |  | $ | 857.55 |  |  | $ | 1,158.30 |  |  |  | 3.4 |  |  | $ | — |
Granted |  |  | — |  |  | $ | — |  |  | $ | — |  |  |  |  |  |  |  | — |
Forfeited |  |  | (484 | ) |  | $ | 590.25 |  |  | $ | 810.30 |  |  |  |  |  |  |  | — |
Outstanding at September 30, 2024 |  |  | 1,538 |  |  | $ | 941.55 |  |  | $ | 1,267.65 |  |  |  | 2.6 |  |  | $ | — |
Exercisable at September 30, 2024 |  |  | 1,477 |  |  | $ | 979.50 |  |  | $ | 1,319.70 |  |  |  | 2.2 |  |  | $ | — |
| A summary of the stock option activity under the Company’s incentive plan for the years ended December 31, 2023 and 2022 is presented below: SCHEDULE OF STOCK OPTION
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Grant Date Fair Value |  |  | Weighted Average Remaining Contractual Term (years) |  |  | Aggregate Intrinsic Value |
Outstanding at January 1, 2022 |  |  | 1,589 |  |  | $ | 1,185 |  |  | $ | 1,552.50 |  |  |  | 5.3 |  |  | $ | 34,333 |
Granted |  |  | 1,700 |  |  | $ | 46.05 |  |  | $ | 38.70 |  |  |  |  |  |  | $ | — |
Forfeited |  |  | (67 | ) |  | $ | 2,625 |  |  | $ | 2,107.50 |  |  |  |  |  |  | $ | — |
Outstanding at December 31, 2022 |  |  | 3,222 |  |  | $ | 555.75 |  |  | $ | 672.30 |  |  |  | 4.1 |  |  | $ | — |
Granted |  |  | — |  |  | $ | — |  |  | $ | — |  |  |  |  |  |  |  | — |
Forfeited |  |  | (1,200 | ) |  | $ | 46.05 |  |  | $ | 38.70 |  |  |  |  |  |  |  | — |
Outstanding at December 31, 2023 |  |  | 2,022 |  |  | $ | 857.55 |  |  | $ | 1,158.30 |  |  |  | 3.4 |  |  | $ | — |
Exercisable at December 31, 2023 |  |  | 1,712 |  |  | $ | 966.75 |  |  | $ | 1,330.80 |  |  |  | 2.9 |  |  | $ | — |
SCHEDULE OF STOCK OPTION ASSUMPTION |  | Options granted during the years ended December 31, 2022 were valued using the Black Scholes model with the following assumptions: SCHEDULE OF STOCK OPTION ASSUMPTION
|  | December 31, 2022 |
Term (years) |  |  | 5.5 |
Stock price |  | $ | 46.05 |
Exercise price |  | $ | 46.05 |
Dividend yield |  |  | — |
Expected volatility |  |  | 112.0 | %
Risk free interest rate |  |  | 3.9 | %
SCHEDULE OF RESTRICTED STOCK UNITS AND AWARDS ACTIVITY | The Company’s activity in restricted stock units was as follows for the nine months ended September 30, 2024: SCHEDULE OF RESTRICTED STOCK UNITS AND AWARDS ACTIVITY
|  | Number of shares |  |  | Weighted average fair value |
Non-vested at December 31, 2023 |  |  | 9,366 |  |  | $ | 434.55 |
Granted |  |  | 16,767 |  |  | $ | 12.75 |
Forfeited |  |  | (650 | ) |  | $ | 43.05 |
Vested |  |  | (2,042 | ) |  | $ | 333.30 |
Non-vested at September 30, 2024 |  |  | 23,441 |  |  | $ | 152.55 |
| The Company’s activity in restricted stock units was as follows for the year ended December 31, 2023: SCHEDULE OF RESTRICTED STOCK UNITS AND AWARDS ACTIVITY
|  | Number of shares |  |  | Weighted average fair value |
Non-vested at January 1, 2022 |  |  | 4,135 |  |  | $ | 1,890 |
Granted |  |  | 2,497 |  |  | $ | 502.50 |
Forfeited |  |  | (1,785 | ) |  | $ | 1,194.60 |
Vested |  |  | (576 | ) |  | $ | 1,958.25 |
Non-vested at December 31, 2022 |  |  | 4,271 |  |  | $ | 1,388.55 |
Granted |  |  | 12,167 |  |  | $ | 40.95 |
Forfeited |  |  | (2,896 | ) |  | $ | 385.80 |
Vested |  |  | (4,176 | ) |  | $ | 297.00 |
Non-vested at December 31, 2023 |  |  | 9,366 |  |  | $ | 434.55 |
SCHEDULE OF STOCK-BASED COMPENSATION FOR RESTRICTED STOCK UNITS | The following table summarizes the Company’s recognition of stock-based compensation for restricted stock units for the following periods: SCHEDULE OF STOCK-BASED COMPENSATION FOR RESTRICTED STOCK UNITS
Stock-based compensation expense for RSUs: |  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
|  | Three Months Ended September |  |  | Nine Months Ended September |
Stock-based compensation expense for RSUs: |  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
General and administrative |  | $ | 162,042 |  |  | $ | 101,607 |  |  | $ | 476,513 |  |  | $ | 946,851 |
Research and development |  |  | 207,158 |  |  |  | 226,646 |  |  |  | 620,057 |  |  |  | 691,514 |
Total |  | $ | 369,200 |  |  | $ | 328,253 |  |  | $ | 1,096,570 |  |  | $ | 1,638,365 |
Stock-based compensation expense for RSUs |  | $ | 369,200 |  |  | $ | 328,253 |  |  | $ | 1,096,570 |  |  | $ | 1,638,365 |
| The following table summarizes the Company’s recognition of stock-based compensation for restricted stock units for the following periods: SCHEDULE OF STOCK-BASED COMPENSATION FOR RESTRICTED STOCK UNITS
|  | 2023 |  |  | 2022 |
|  | Year ended December 31, |
|  | 2023 |  |  | 2022 |
Stock-based compensation expense for RSUs: |  |  |  |  |  |  |  |
General and administrative |  | $ | 1,085,791 |  |  | $ | 1,389,359 |
Research and development |  |  | 908,294 |  |  |  | 1,026,907 |
Total |  | $ | 1,994,085 |  |  | $ | 2,416,266 |
Stock-based compensation expense for RSUs |  | $ | 1,994,085 |  |  | $ | 2,416,266 |
SCHEDULE OF WARRANTS OUTSTANDING | The following table summarizes information about shares issuable under warrants outstanding at September 30, 2024: SCHEDULE OF WARRANTS OUTSTANDING
|  | Warrant shares outstanding |  |  | Weighted average exercise price |  |  | Weighted average remaining life |  |  | Intrinsic value |
Outstanding at December 31, 2023 |  |  | 186,614 |  |  | $ | 176.85 |  |  |  | 4.6 |  |  | $ | — |
Expired |  |  | (39 | ) |  |  | 2,400.00 |  |  |  | — |  |  | $ | — |
Exercised |  |  | (130,267 | ) |  |  | 20.55 |  |  |  | — |  |  | $ | — |
Outstanding at September 30, 2024 |  |  | 56,308 |  |  | $ | 536.70 |  |  |  | 3.0 |  |  | $ | — |
Exercisable at September 30, 2024 |  |  | 56,308 |  |  | $ | 536.70 |  |  |  | 3.0 |  |  | $ | — |
| The following table summarizes information about shares issuable under warrants outstanding at December 31, 2023 and 2022: SCHEDULE OF WARRANTS OUTSTANDING
|  | Warrant shares outstanding |  |  | Weighted average exercise price |  |  | Weighted average remaining life |  |  | Intrinsic value |
Outstanding at January 1, 2022 |  |  | 13,031 |  |  | $ | 1,965 |  |  |  | 3.4 |  |  | $ | 801,024 |
Issued |  |  | 81,834 |  |  | $ | 154.65 |  |  |  |  |  |  | $ | — |
Exercised |  |  | (51,167 | ) |  | $ | — |  |  |  |  |  |  | $ | — |
Exchanged for common stock |  |  | — |  |  | $ | — |  |  |  |  |  |  | $ | — |
Outstanding at December 31, 2022 |  |  | 43,698 |  |  | $ | 875.40 |  |  |  | 3.6 |  |  | $ | 5,514 |
Issued |  |  | 154,088 |  |  | $ | 20.55 |  |  |  |  |  |  | $ | — |
Exercised |  |  | (8,134 | ) |  | $ | 20.55 |  |  |  |  |  |  | $ | — |
Forfeited |  |  | (3,038 | ) |  | $ | 1,672.50 |  |  |  |  |  |  | $ | — |
Outstanding at December 31, 2023 |  |  | 186,614 |  |  | $ | 176.85 |  |  |  | 4.6 |  |  | $ | — |
Exercisable at December 31, 2023 |  |  | 186,614 |  |  | $ | 176.85 |  |  |  | 4.6 |  |  | $ | — |
SCHEDULE OF INVESTMENT OPTIONS | The following table summarizes information about investment options outstanding at September 30, 2024: SCHEDULE OF INVESTMENT OPTIONS
|  | Investment options outstanding |  |  | Weighted average exercise price |  |  | Weighted average remaining life |  |  | Intrinsic value |
Outstanding at December 31, 2023 |  |  | 4,667 |  |  | $ | 150.00 |  |  |  | 4.1 |  |  | $ | — |
Outstanding at September 30, 2024 |  |  | 4,667 |  |  | $ | 150.00 |  |  |  | 2.9 |  |  | $ | — |
Exercisable at September 30, 2024 |  |  | 4,667 |  |  | $ | 150.00 |  |  |  | 2.9 |  |  | $ | — |
| The following table summarizes information about investment options outstanding at December 31, 2023 and 2022: SCHEDULE OF WARRANTS AND INVESTMENT OPTIONS
|  | Investment options outstanding |  |  | Weighted average exercise price |  |  | Weighted average remaining life |  |  | Intrinsic value |
Outstanding at January 1, 2022 |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Issued |  |  | 71,334 |  |  | $ | 118.95 |  |  |  | — |  |  |  | — |
Outstanding at December 31, 2022 |  |  | 71,334 |  |  | $ | 118.95 |  |  |  | 5.1 |  |  | $ | — |
Exercised |  |  | (66,667 | ) |  | $ | 20.55 |  |  |  | — |  |  |  | — |
Outstanding at December 31, 2023 |  |  | 4,667 |  |  | $ | 150.00 |  |  |  | 4.1 |  |  | $ | — |
Exercisable at December 31, 2023 |  |  | 4,667 |  |  | $ | 150.00 |  |  |  | 4.1 |  |  | $ | — |
SCHEDULE OF BLACK SCHOLES VALUATION MODEL FOR VALUATION OF WARRANTS |  | The Company established the initial fair value of its equity classified Inducement Warrants at the date of issuance on December 28, 2023. The Company used a Black Scholes valuation model in order to determine their value. The key inputs into the Black Scholes valuation model for the valuation of the warrants are below: SCHEDULE OF BLACK SCHOLES VALUATION MODEL FOR VALUATION OF WARRANTS
|  | Roth and Inducement Warrants |
|  | December 28, 2023 |
Term (years) |  |  | 5.0 |
Stock price |  | $ | 23.40 |
Exercise price |  | $ | 20.55 |
Dividend yield |  |  | — | %
Expected volatility |  |  | 92.0 | %
Risk free interest rate |  |  | 3.80 | %
Number of warrants |  |  | 154,088 |
Value (per share) |  | $ | 17.40 |

X
- Definition Schedule Of Valuation Of Warrants [Text Block] + References No definition available. + Details
Name: | ENVB_ScheduleOfValuationOfWarrantsTextBlock
Namespace Prefix: | ENVB_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of warrants outstanding [Table Text Block] + References No definition available. + Details
Name: | ENVB_ScheduleOfWarrantsOutstandingTableTextBlock
Namespace Prefix: | ENVB_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration